Aesica Appoints Commercial Managing Director - - BioPharm International

ADVERTISEMENT

Aesica Appoints Commercial Managing Director



Aesica, a CDMO, has appointed Ian Muir to the newly created position of commercial managing director, effective on February 24. Muir’s responsibilities will cross all three of the company’s service offerings in API manufacturing, formulation development, and formulated products. He will also lead the expansion of the business into new markets, including China and Japan. Muir will report directly to Robert Hardy, CEO, and will be joining the Aesica Board.

Previously, Muir worked at Catalent where he was responsible for the global provision of contract development and manufacturing services for oral dose forms. He also has commercial experience in contract manufacturing roles for pharmaceutical companies located in Europe, the US, and Australia.

Source: Aesica
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines

Click here